TNFRSF12A/TWEAKR hFc Chimera, Human

Item number	Size	Datasheet	Manual	SDS	Delivery time	Quantity	Price
GSC-Z05899-100	100 µg		-		7 - 10 business days*		349.00€
GSC-Z05899-500	500 µg		-		7 - 10 business days*		1,169.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant... more

Close menu

Product information "TNFRSF12A/TWEAKR hFc Chimera, Human"

Thyroid cancer (TC) is the most well-known endocrine neoplasia as well as a common malignant tumor in the head and neck.TNFRSF12A expression may be a potential useful prognostic molecular biomarker of bad survival in thyroid cancer, in addition, PPAR signaling pathway, insulin signaling pathway, mTOR signaling pathway may be the key pathway controlled by TNFRSF12A in thyroid cancer. Further experimental ought to be performed to demonstrate the biologic effect of TNFRSF12A.

Keywords:	TNFRSF12A, Tweak-receptor, Tumor necrosis factor receptor superfamily member 12A, Fibroblast growth factor-inducible immediate-early response protein 14
Supplier:	GenScript
Supplier-Nr:	Z05899

Properties

Conjugate:	No
Species reactivity:	human
MW:	32.9 kD
Purity:	>95% (Bis-Tris PAGE)

Database Information

KEGG ID :	K05149 \| Matching products
UniProt ID :	Q9NP84 \| Matching products
Gene ID :	GeneID 51330 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: °C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "TNFRSF12A/TWEAKR hFc Chimera, Human"

Write a review